Medical News

RSS

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides, Inc. (the "Company"), reports that the Company has been invited to present on January 12th at the Biotech Showcase™, a conference designed to showcase promising companies and technologies for partnering and investment purposes.

12 Jan 2010

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company’s increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.

12 Jan 2010

GeckoSystems' CEO issues 2009 year end open letter to stockholders

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that a 2009 year's end letter from their CEO can be viewed at their website, or Pinksheets.com.

12 Jan 2010

Public health and environment at risk: Large tobacco company influences EU policymaking

One of the world's largest tobacco companies has been instrumental in pushing through fundamental changes to EU policymaking, researchers from the University of Bath have found.

12 Jan 2010

Product quality becomes important to end users in sterilisation and disinfection equipment market

Due to the lack of adequate financing and weak healthcare infrastructure, price sensitivity within the Eastern European sterilisation and disinfection equipment market remains high.

12 Jan 2010

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists.

12 Jan 2010

Israeli Minister of Science and Technology visits BrainStorm Cell Therapeutics; reviews ALS clinical trials

BrainStorm Cell Therapeutics Inc.(OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that it received a visit yesterday by the Israeli Minister of Science and Technology, Professor Daniel Hershkowitz. The

12 Jan 2010

Experts to present latest research findings on reproductive medicine at ESHRE 26th annual meeting

Reproductive medicine is one of the most exciting scientific and clinical areas. Every month different announcements of research developments, medical 'firsts', new rulings by regulatory bodies, or ethical controversies are published and often spark a heated debate among practitioners in the field, as well as ethicists, legislators, the media and the public.

12 Jan 2010

Health Press NA releases new children’s bibliotherapy book on separation anxiety

Health Press NA Inc. (www.healthpress.com) releases a new children’s bibliotherapy book regarding separation anxiety. Bug Bites and Campfires: A Story for Kids About Homesickness addresses anxiety and homesickness in a delightful story about going away to camp.

12 Jan 2010

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation's Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer's disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these positive data would promote the use of Dimebon throughout the course of the disease.

12 Jan 2010

Stanford University School of Medicine adopts new, industry-funded model for continuing physicians’ education

Stanford University School of Medicine has developed a new, industry-funded model for the continuing education of physicians that aims to improve patient care while ensuring that corporate donors do not exert influence over the curriculum.

12 Jan 2010

U.S. physicians can receive interest-free loan from Ingenix to license and implement CareTracker EHR

Ingenix today introduced a package that includes interest-free financing, health information technology (HIT) services and performance guarantees to help physicians integrate HIT into their practices.

12 Jan 2010

Study: Large amount of money in wasted claims expense is missed by organizations relying on random-sample methodology

With healthcare expenses increasing by up to double digits annually and self-insured employers providing the majority of healthcare benefits for insured Americans, identifying wasted health plan expense has never been more important. A common tool for doing this is the random-sample, retrospective audit of an employee health plan's past one or two years of paid claims.

12 Jan 2010

SAC named alpha site for AQI's first national anesthesia data registry

Southeast Anesthesiology Consultants (SAC) has become an alpha site for the first national anesthesia data registry developed by the Anesthesia Quality Institute (AQI).

12 Jan 2010

Synexus finalises acquisition of ClinPharm at the start of 2010

Following their recent announcement of the deal to acquire German company, ClinPharm, Manchester-based Synexus is celebrating the start of 2010 with the news that the acquisition has now been finalised. This increases the number of Synexus dedicated research centres to twenty-six.

From AES - Accelerated Enrollment Solutions 12 Jan 2010

Curemark retains Rubenstein Public Relations

Curemark, a drug research and development company that focuses on the treatment of neurological diseases, has retained Rubenstein Public Relations to help raise national, regional, and industry awareness of the organization's research, treatments and founder, Dr. Joan Fallon. Curemark is developing an autism treatment that will be one of the first to address the underlying physiology of autism.

12 Jan 2010

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).

12 Jan 2010

New GAO report shows price increase for brand-name drugs doubles from 2000 to 2008

A new report from the Government Accountability Office (GAO) that finds “extraordinary price increases” for brand-name drug products from 2000 – 2008 was largely fueled by the “lack of therapeutically equivalent drugs” and “limited competition,” underscores the need for policymakers to promote policies in health reform which increase competition and lower costs, the Pharmaceutical Care Management Association (PCMA) said today.

12 Jan 2010

HMP Communications' Managed Care – First Report journal to be rebranded as First Report – Managed Care

HMP Communications, a leader in healthcare communications and education, announced today that its highly-rated Managed Care – First Report journal will be rebranded as First Report – Managed Care, covering clinical, economic, and legislative developments affecting managed markets, beginning with its January 2010 issue.

12 Jan 2010

BioTrends Research Group releases Wave One LaunchTrends: EXTAVIA report

BioTrends Research Group, Inc. announces the release of the Wave One LaunchTrends(®): EXTAVIA report. The survey was completed by U.S. Neurologists Extavia (Interferon beta 1b).

12 Jan 2010

Medical News

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

GeckoSystems' CEO issues 2009 year end open letter to stockholders

Public health and environment at risk: Large tobacco company influences EU policymaking

Product quality becomes important to end users in sterilisation and disinfection equipment market

Market for chronic tophaceous gout medications will be led by drug that resolves tophi in less than a year

Israeli Minister of Science and Technology visits BrainStorm Cell Therapeutics; reviews ALS clinical trials

Experts to present latest research findings on reproductive medicine at ESHRE 26th annual meeting

Health Press NA releases new children’s bibliotherapy book on separation anxiety

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Stanford University School of Medicine adopts new, industry-funded model for continuing physicians’ education

U.S. physicians can receive interest-free loan from Ingenix to license and implement CareTracker EHR

Study: Large amount of money in wasted claims expense is missed by organizations relying on random-sample methodology

SAC named alpha site for AQI's first national anesthesia data registry

Synexus finalises acquisition of ClinPharm at the start of 2010

Curemark retains Rubenstein Public Relations

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

New GAO report shows price increase for brand-name drugs doubles from 2000 to 2008

HMP Communications' Managed Care – First Report journal to be rebranded as First Report – Managed Care

BioTrends Research Group releases Wave One LaunchTrends: EXTAVIA report

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News